Long-Term Follow-up of Subjects Who Were Treated With ST-920 | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Long-Term Follow-up of Subjects Who Were Treated With ST-920	Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, Cerebral Small Vessel Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Fabry Disease, Cardiac Variant, Fabry disease, Lipid Metabolism Disorders, Lipid Metabolism, Inborn Errors, Lysosomal Storage Diseases, Nervous System, Nutritional and Metabolic Diseases, X-linked disease, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, hereditary disease, inborn errors of metabolism, lysosomal lipid storage disorder, lysosomal storage disease, metabolic disease, nervous system disorder, sphingolipidosis, vascular disorder	Active, not recruiting	Not stated	2026-08-20		NCT05039866

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Sangamo Therapeutics	5

13 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Addenbrooke's Hospital	Cambridge	United Kingdom	40
Cincinnati Children's Hospital Medical Center	Cincinnati	United States	405
Emory University School of Medicine	Atlanta	United States	47
Lysosomal & Rare Disorders Research & Treatment Center (LDRTC)	Fairfax	United States	1
M.A.G.I.C. Clinic Ltd.	Calgary	Canada	1
Mt. Sinai Hospital	New York	United States	2
Royal Free Hospital	London	United Kingdom	24
The Royal Melbourne Hospital	Parkville	Australia	26
University Hospital of Würzburg	Würzburg	Germany	5
University of California, Irvine	Irvine	United States	32
University of Iowa Hospital and Clinics	Iowa City	United States	30
University of Minnesota Medical Center	Minneapolis	United States	21
University of South Florida	Tampa	United States	33